ZA200107368B - Immunostimulant bacterial membrane fractions in cancer treatment - Google Patents

Immunostimulant bacterial membrane fractions in cancer treatment

Info

Publication number
ZA200107368B
ZA200107368B ZA2001/07368A ZA200107368A ZA200107368B ZA 200107368 B ZA200107368 B ZA 200107368B ZA 2001/07368 A ZA2001/07368 A ZA 2001/07368A ZA 200107368 A ZA200107368 A ZA 200107368A ZA 200107368 B ZA200107368 B ZA 200107368B
Authority
ZA
South Africa
Prior art keywords
immunostimulant
cancer treatment
membrane fractions
bacterial membrane
preparing
Prior art date
Application number
ZA2001/07368A
Other languages
English (en)
Inventor
Beck Alain
Corvaia Nathalie
Libon Christine
Yves BONNEFOY Jean
Original Assignee
Pierre Fabre Madicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Madicament filed Critical Pierre Fabre Madicament
Publication of ZA200107368B publication Critical patent/ZA200107368B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ZA2001/07368A 1999-03-15 2001-09-06 Immunostimulant bacterial membrane fractions in cancer treatment ZA200107368B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903154A FR2790960B1 (fr) 1999-03-15 1999-03-15 Utilisation de fractions membranaires bacteriennes a activite immunostimulante dans le traitement de cancers, leurs procedes de preparation et les compositions pharmaceutiques les contenant
PCT/FR2000/000623 WO2000054790A1 (fr) 1999-03-15 2000-03-15 Fractions membranaires bacteriennes immunostimulantes dans le traitement de cancers

Publications (1)

Publication Number Publication Date
ZA200107368B true ZA200107368B (en) 2002-06-26

Family

ID=9543185

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2001/07368A ZA200107368B (en) 1999-03-15 2001-09-06 Immunostimulant bacterial membrane fractions in cancer treatment

Country Status (14)

Country Link
US (1) US7033591B1 (https=)
EP (1) EP1161250B9 (https=)
JP (1) JP2002539170A (https=)
CN (1) CN1202127C (https=)
AT (1) ATE302014T1 (https=)
AU (1) AU776350B2 (https=)
BR (1) BR0009052A (https=)
CA (1) CA2367211A1 (https=)
DE (1) DE60022011T2 (https=)
DK (1) DK1161250T3 (https=)
ES (1) ES2246831T3 (https=)
FR (1) FR2790960B1 (https=)
WO (1) WO2000054790A1 (https=)
ZA (1) ZA200107368B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2808445A1 (fr) * 2000-05-04 2001-11-09 Pf Medicament Proteine omp associee a un lysat de cellules tumorales autologues et/ou heterologues
FR2809014A1 (fr) * 2000-05-16 2001-11-23 Pf Medicament Utilisation d'une proteine ompa d'enterobacterie comme agent antimicrobien
GB2370838A (en) * 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex
FR2822071B1 (fr) * 2001-03-15 2005-07-01 Pf Medicament Utilisation d'une fraction membranaire de bacteries a gram negatif pour induire la maturation des cellules dendritiques
EP4241853B1 (en) * 2013-11-26 2026-02-11 Zoetis Services LLC Compositions for induction of immune response
GB201713975D0 (en) * 2017-08-31 2017-10-18 Macrophage Pharma Ltd Medical use
CN113727722A (zh) * 2019-02-22 2021-11-30 伊夫罗生物科学公司 细菌膜制剂
EP4190894A1 (en) 2021-12-03 2023-06-07 CiMaas B.V. Method for the production of mature dendritic cells in vitro using a bacterial lysate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
FR2596064B1 (fr) * 1986-03-18 1990-02-02 Pf Medicament Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
AU603585B2 (en) * 1986-05-07 1990-11-22 Sloan-Kettering Institute For Cancer Research Vaccine for stimulating or enhancing production of antibodies directed against GM2
AU7477791A (en) * 1990-03-02 1991-09-18 Joaquin J. Jimenez Method for treating cancer using combination chemotherapy and brm
US5242806A (en) * 1990-05-07 1993-09-07 Baxter Diagnostics Inc. Method for conducting the cytotoxicity assays on tumor cells
US5776898A (en) * 1991-05-14 1998-07-07 Dana-Farber Cancer Institute Method for treating a tumor with a chemotherapeutic agent
US5830686A (en) * 1994-01-13 1998-11-03 Calydon Tissue-specific enhancer active in prostate
FR2726472B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
FR2785542B1 (fr) * 1998-11-06 2001-02-09 Pf Medicament UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES

Also Published As

Publication number Publication date
CN1343125A (zh) 2002-04-03
CN1202127C (zh) 2005-05-18
AU3298100A (en) 2000-10-04
EP1161250B1 (fr) 2005-08-17
EP1161250B9 (fr) 2006-07-05
JP2002539170A (ja) 2002-11-19
DE60022011T2 (de) 2006-06-14
FR2790960B1 (fr) 2002-10-31
DE60022011D1 (de) 2005-09-22
BR0009052A (pt) 2001-12-26
US7033591B1 (en) 2006-04-25
ATE302014T1 (de) 2005-09-15
WO2000054790A1 (fr) 2000-09-21
CA2367211A1 (fr) 2000-09-21
FR2790960A1 (fr) 2000-09-22
AU776350B2 (en) 2004-09-02
EP1161250A1 (fr) 2001-12-12
ES2246831T3 (es) 2006-03-01
DK1161250T3 (da) 2005-12-12

Similar Documents

Publication Publication Date Title
WO1999025367A3 (en) Treatment of hematologic disorders
SG157951A1 (en) Cripto blocking antibodies and uses thereof
WO2004018000A3 (en) Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents
HUP0203238A3 (en) Drugs for the treatment of malignant tumours, process for their preparation and pharmaceutical compositions containing them
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
IL110045A (en) Pharmaceutical compositions containing oligopeptides for combating AIDS and ARC and for immune stimulation and certain such novel oligopeptides
WO2003083041A3 (en) Cripto-specific antibodies
BG102708A (en) 4-aminopyrimidine derivatives, medicamentous preparations containing them, their application and method for their preparation
IL146125A0 (en) Novel quinones as disease therapies
CA2223817A1 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
HUP0400231A3 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
HK1052301A1 (zh) α(2)巨球蛋白与抗原分子的复合物作免疫治疗用途
TW200600091A (en) Sulfonylethyl phosphorodiamidates
TR199501654A3 (https=)
ZA200107368B (en) Immunostimulant bacterial membrane fractions in cancer treatment
CA2081343A1 (fr) Agents therapeutiques pour le traitement de la resistance multi-drogue dans les cas de cancer
CA2131565A1 (en) Organopolysiloxanes Containing Hydrophilic Groups
AU4414400A (en) Lactic acid bacteria with anxiolytic properties and uses thereof
AU6698000A (en) Bifidobacteria capable of preventing diarrhea
ZA200106725B (en) Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral antiparasitic or antitumoral cytotoxic response.
ES2013321A6 (es) Un metodo de produccion de anticuerpos monoclonales
ZA991410B (en) Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
AU4558201A (en) Taxane anticancer agents
ATE346602T1 (de) Bakterienwandfraktionen mit adjuvansaktivität